China Health Technology Details Board and Committee Structure

China Bozza Development Holdings Limited ( (HK:1069) ) just unveiled an update.

China Health Technology Group Holding Company Limited has announced the current composition of its board of directors and the allocation of roles across its key governance committees. Chairman and CEO Ms. Bu Xue serves as an executive director, alongside executive director Ms. Cao Xiying, while independent non-executive directors Mr. Chau Wing Nam, Ms. Liu Shuhua and Mr. Li Liangjie provide oversight, with Mr. Chau chairing the Audit, Remuneration and Nomination committees. The disclosure underscores the company’s emphasis on independent oversight and committee-based governance, a structure that may bolster investor confidence in its board independence and internal control framework.

The most recent analyst rating on (HK:1069) stock is a Hold with a HK$0.45 price target. To see the full list of analyst forecasts on China Bozza Development Holdings Limited stock, see the HK:1069 Stock Forecast page.

More about China Bozza Development Holdings Limited

China Health Technology Group Holding Company Limited, listed in Hong Kong under stock code 1069 and incorporated in the Cayman Islands, operates in the health technology sector. The company is overseen by a board comprising executive and independent non-executive directors, reflecting a typical governance structure for a Hong Kong-listed health-related enterprise.

Average Trading Volume: 381,230

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$42.71M

For an in-depth examination of 1069 stock, go to TipRanks’ Overview page.